the Image

Clinical Trial Details

If you are a patient or a caregiver and would like to learn more our cancer clinical trials call toll-free 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials) or email cancerclinicaltrials@bsd.uchicago.edu .

Share this:
Brief Title Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
Official Title (INTREPID-1) A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
Principal Investigator Jakubowiak, Andrzej
Brief Summary A study evaluating two new formulations of oprozomib plus pomalidomide and dexamethasone in patients with relapsed refractory multiple myeloma.
Gender All
Ages 18 Years
Enrollment 64
Accepts Healthy Volunteers No
Lead Sponsor AmgenIndustry
Collaborator
Study Design
Study Phase Phase 1
Study Type Interventional
Contact Name
Contact Phone 1-855-702-8222 (adult trials) or 1-773-702-6808 (pediatric trials)
Condition Relapsed or Refractory Multiple Myeloma
Detail for Health Professional (on clinicaltrials.gov)
More clinical trials by this PI